Cytokines and signaling molecules predict clinical outcomes in sepsis

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Fjell, Christopher D ^a   Thair, Simone ^a   Hsu, Joseph L ^b   Walley, Keith R ^a   Russell, James A ^a   Boyd, John ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CXCL1 CHEMOKINE; CYTOKINE; EOTAXIN; FIBROBLAST GROWTH FACTOR 2; FRACTALKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; MACROPHAGE DERIVED CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; CLUSTER ANALYSIS; CONTROLLED STUDY; DEATH; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PREDICTION; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

AGED; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMOSTATICS; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; NOREPINEPHRINE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEPSIS; SURVIVAL RATE; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 84896701211     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079207     Document Type: Article

References (16)

1. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, et al. (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358: 877-887. doi:10.1056/NEJMoa067373. (Pubitemid 351397087)
2. Russell JA (2011) Bench-to-bedside review: Vasopressin in the management of septic shock. Crit Care 15: 226. doi:10.1186/cc8224.
3. Rivers EP, Jaehne AK, Nguyen HB, Papamatheakis DG, Singer D, et al. (2013) Early Biomarker Activity in Severe Sepsis and Septic Shock and A Contemporary Review of Immunotherapy Trials. Shock: 1. doi:10.1097/SHK. 0b013e31827dafa7.
4. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368-1377. doi:10.1056/NEJMoa010307.
5. Riedemann NC, Guo R-F, Ward PA (2003) Novel strategies for the treatment of sepsis. Nat Med 9: 517-524. doi:10.1038/nm0503-517. (Pubitemid 36597096)
6. Gogos CA, Drosou E, Bassaris HP, Skoutelis A (2000) Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis 181: 176-180. doi:10.1086/315214. (Pubitemid 30049046)
7. Lyn-Kew K, Standiford TJ (2008) Immunosuppression in sepsis. Curr Pharm Des 14: 1870-1881.
8. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, et al. (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167: 1655-1663. doi:10.1001/archinte.167.15.1655. (Pubitemid 47280347)
9. Yende S, D'Angelo G, Kellum JA, Weissfeld L, Fine J, et al. (2008) Inflammatory Markers at Hospital Discharge Predict Subsequent Mortality after Pneumonia and Sepsis. Am J Respir Crit Care Med 177: 1242-1247. doi:10.1164/rccm.200712-1777OC. (Pubitemid 351860933)
10. Patel RT, Deen KI, Youngs D, Warwick J, Keighley MR (1994) Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br J Surg 81: 1306-1308. (Pubitemid 24275149)
11. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119: 771-778. (Pubitemid 24012641)
12. Heper Y, Akalin EH, Mistik R, Akgöz S, Töre O, et al. (2006) Evaluation of serum C-reactive protein, procalcitonin, tumor necrosis factor alpha, and interleukin-10 levels as diagnostic and prognostic parameters in patients with community-acquired sepsis, severe sepsis, and septic shock. Eur J Clin Microbiol Infect Dis 25: 481-491. doi:10.1007/s10096-006-0168-1.
13. Marchant A, Alegre ML, Hakim A, Piérard G, Marécaux G, et al. (1995) Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 15: 266-273.
14. Rongione AJ, Kusske AM, Kwan K, Ashley SW, Reber HA, et al. (2000) Interleukin-10 protects against lethality of intra-abdominal infection and sepsis. J Gastrointest Surg 4: 70-76.
15. Russell JA, Fjell C, Hsu JL, Lee T, Boyd J, et al. (2013) Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock. Am J Respir Crit Care Med 188: 356-364. doi:10.1164/rccm.201302- 0355OC.
16. Lvovschi V, Arnaud L, Parizot C, Freund Y, Juillien G, et al. (2011) Cytokine Profiles in Sepsis Have Limited Relevance for Stratifying Patients in the Emergency Department: A Prospective Observational Study. PLoS ONE 6:e28870. doi:10.1371/journal.pone.0028870.t007.